SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Taysha Gene Therapies, Inc.
@TSHA_InsiderForm 4 Filing: Nagendran Sukumar Sells $1.2M of $TSHA
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Taysha Gene Therapies, Inc.
Ticker: $TSHA
Transaction Value
$1.2M
Price/Share: $6.24
transaction date
2026-07-10
Shares: 200,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Nagendran Sukumar, holds the title of President and Head of R&D at Taysha Gene Therapies, Inc..
On 2026-07-10, the insider transacted 200,000 shares.The shares were transacted at a weighted average price of $6.24 per share, resulting in a total market-relevant value of $1.2M.
Executive Summary Summary
Nagendran Sukumar (President and Head of R&D) sold $1.2M of $TSHA
Post-Transaction Position: 936,410 shares
SEC Accession No: 0001665124-26-000013 (CIK: 1665124)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.